No Data
No Data
Hong Kong stock Concept tracking | Promoting the value assessment and allocation of Traditional Chinese Medicine Pharmaceuticals, Institutions are Bullish on the recovery of Traditional Chinese Medicine revenue (with attached Concept stocks)
The General Office of the State Council issued the "Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High-Quality Development of the Traditional Chinese Medicine Industry."
Express News | State Council: Improve the quality of Traditional Chinese Medicine to promote the high-quality development of the Traditional Chinese Medicine industry.
The profit warning from PURAPHARM (01498.HK) forecasts that last year's loss has decreased to 36 million yuan.
PURAPHARM (01498.HK) issued a profit warning, predicting a loss of no more than 36 million yuan for the year 2024, compared to a loss of 0.106 billion yuan recorded in the previous year. The significant decrease in net loss is primarily due to a reduction in the fair value loss of biological assets related to the group's planting segment; as well as a substantial decrease in administrative expenses and sales and distribution expenses.
PuraPharm Projects Reduced Losses for FY2024 Amid Cost Control Efforts
PURAPHARM (01498) has issued a profit warning, expecting an annual net loss of no more than approximately 36 million Hong Kong dollars, a significant reduction compared to the same period last year.
PURAPHARM (01498) announced that the group expects to incur a net loss of no more than approximately 36... for the fiscal year 2024.
PURAPHARM: UPDATES OF FINANCIAL PERFORMANCEFOR THE YEAR ENDED 31 DECEMBER 2024